Urticarial Reaction to Ustekinumab During the Treatment of Plaque Psoriasis in a Hepatitis C-Positive Patient

Drug Safety - Case Reports - Switzerland
doi 10.1007/s40800-017-0051-2
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Risankizumab Versus Ustekinumab for Plaque Psoriasis: A Critical Appraisal

British Journal of Dermatology
DermatologyMedicine
2019English

Squamous Cell Carcinoma of the Tongue in a Patient on Ustekinumab as the Treatment of Psoriasis

Journal of Clinical Research in Dermatology
2017English

Pss17 - Cost Per Responder Analysis of Brodalumab Compared With Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Image Gallery: Resolution of Lichen Striatus in a Patient With Coexisting Chronic Plaque Psoriasis and Vitiligo During Secukinumab Treatment

British Journal of Dermatology
DermatologyMedicine
2017English

Infliximab for the Treatment of Plaque Psoriasis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Hydroxychloroquine Enhanced Urticarial Reaction in a Patient With Discoid Lupus Erythematosus

Trends in Immunotherapy
2017English

Risankizumab for the Treatment of Plaque Psoriasis in Adults

Prescriber
Pharmacology
2019English

Patient-To-Patient Transmission of Hepatitis C Virus (HCV) During Colonoscopy Diagnosis

Virology Journal
VirologyInfectious Diseases
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy